Defining uremic arterial functional abnormalities in patients recently started on haemodialysis: combined in vivo and ex vivo assessment

A M Abushufa, M T Eldehni, A Odudu, P D Evans, S E O'Sullivan, C W McIntyre

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Endothelial dysfunction is a key initiating event in vascular disease in chronic kidney disease (CKD) patients and haemodialysis (HD) patients exhibit significant vascular abnormalities. To understand this further, we examined how ex vivo intrinsic function in isolated arteries correlates with in vivo assessments of cardiovascular status in HD patients. Abdominal fat biopsies were obtained from 11 HD patients and 26 non-uremic controls. Subcutaneous arteries were dissected and mounted on a wire myograph, and cumulative concentration-response curves to noradrenalin, endothelin-1, a thromboxane A2 agonist (U46619), angiotensin II, vasopressin, bradykinin (BK), acetylcholine (ACh) and sodium nitroprusside (SNP) were constructed. Pulse wave velocity and blood pressure were measured in HD patients. Enhanced (P600 microm. The potency (pEC50) of U46619 (P600 microm of HD patients. The maximal relaxant response to the endothelium-dependent dilators ACh and BK were lower in HD patients (P
    Original languageEnglish
    JournalPLoS ONE
    Volume9
    Issue number12
    DOIs
    Publication statusPublished - 2014

    Fingerprint

    Dive into the research topics of 'Defining uremic arterial functional abnormalities in patients recently started on haemodialysis: combined in vivo and ex vivo assessment'. Together they form a unique fingerprint.

    Cite this